Search - tctmd.com

Displaying 601 - 614 of 614

Sort: Relevancy | Date

News Daily News

Higher BMI Linked to Lower Mortality, More Metabolic Disorders After PCI

L.A. McKeown

April 12, 2011

News Daily News

Meta-analysis: Benefits of High-Dose Statins Confirmed Prior to PCI

Jason Kahn

April 11, 2011

News Daily News

Mortality Benefit with Primary PCI vs. Thrombolysis Restricted to High-Risk Patients

Jason Kahn

March 31, 2011

News Daily News

Meta-analysis: Renal Intervention Reduces BP Drugs, Not Outcomes

Caitlin E. Cox

March 18, 2011

News Daily News

Aspirin’s GI Bleeding Risk Increased by Concomitant Use of Gastrotoxic Drugs

Caitlin E. Cox

March 10, 2011

News Daily News

Women Less Likely to Receive Evidence-Based Therapies Than Men

Jason Kahn

March 09, 2011

News Daily News

In-Hospital Mortality Equal for Men, Women After PCI for STEMI

Caitlin E. Cox

February 08, 2011

News Daily News

Improvements in Care for PCI Patients with PAD Fail to Budge Mortality, MI Rates

February 07, 2011

News Daily News

High-Dose Maintenance Clopidogrel Lowers Platelet Reactivity, Other Risk Factors

February 06, 2011

News Daily News

Another Study Finds No Interaction Between PPIs and Clopidogrel

L.A. McKeown

January 27, 2011

News Daily News

More Than 1 in 10 Patients Discontinue Antiplatelet Therapy Early

L.A. McKeown

January 24, 2011

News Daily News

CILON-T Published: Cilostazol Reduces Platelet Reactivity, Not Events

January 09, 2011

News Daily News

Year in Review: Highlights of 2010 Include Data on Valvular Therapy, CTA Progress

Caitlin E. Cox

January 02, 2011

News Daily News

JUPITER: Rosuvastatin Cuts Heart Risk, Even In LDL-Normal Patients

November 11, 2008

Advertisement

Higher BMI Linked to Lower Mortality, More Metabolic Disorders After PCI

Meta-analysis: Benefits of High-Dose Statins Confirmed Prior to PCI

Mortality Benefit with Primary PCI vs. Thrombolysis Restricted to High-Risk Patients

Meta-analysis: Renal Intervention Reduces BP Drugs, Not Outcomes

Aspirin’s GI Bleeding Risk Increased by Concomitant Use of Gastrotoxic Drugs

Women Less Likely to Receive Evidence-Based Therapies Than Men

In-Hospital Mortality Equal for Men, Women After PCI for STEMI

Improvements in Care for PCI Patients with PAD Fail to Budge Mortality, MI Rates

High-Dose Maintenance Clopidogrel Lowers Platelet Reactivity, Other Risk Factors

Another Study Finds No Interaction Between PPIs and Clopidogrel

More Than 1 in 10 Patients Discontinue Antiplatelet Therapy Early

CILON-T Published: Cilostazol Reduces Platelet Reactivity, Not Events

Year in Review: Highlights of 2010 Include Data on Valvular Therapy, CTA Progress

JUPITER: Rosuvastatin Cuts Heart Risk, Even In LDL-Normal Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content